Takeda Agrees to Pay $2.4 Billion to Settle Suits Over Cancer Risk of Actos

$2.4 Billion to Settle Suits Over Cancer Risks of Actos Takeda has just agreed to pay out $2.4 billion to settle lawsuits related to the carcinogenic effects of Actos Takeda has settled with The company stated that the huge thousands of people and their families who claimed that the company's diabetes medication called multi-billion dollar settlement would resolve a majority of the product liability lawsuits related to Actos. Actos caused bladder cancer. Currently there are aound 9,000 different bladder cancer claims pending against Takeda because of their drug, Actos. Last year a jury in Louisiana The lawyers who are representing the plaintiffs in ordered Takeda as well as Eli Lilly to pay out $9 billion these cases stated that Takeda knowingly concealed the medication's ability in punitive damages after it was determined that Takeda withheld the cancer to cause bladder cancer. risks of its medication. Takeda did not admit any wrongdoing, essentially stating that it has settled to avoid further legal proceedings against the company. The settlement will become official if and when 95% of the plaintiffs agree to it, which would mean that Takeda would be required to pay out $2.37 billion. If 97% of the plaintiffs agree, Takeda will have to pay out $2.4 billion.